Arcadia Biosciences Inc

NASDAQ RKDA

Data sourced from

and

Download Data

Arcadia Biosciences Inc Gross Profit Margin for the year ending December 31, 2023: 38.09%

Arcadia Biosciences Inc Gross Profit Margin is 38.09% for the year ending December 31, 2023, a 2,362.25% change year over year. Gross Profit Margin represents the percentage of revenue that represents gross profit, indicating the efficiency of a company's production and pricing.

Arcadia Biosciences Inc Gross Profit Margin for the year ending December 31, 2022 was 1.55%, a 105.44% change year over year.
Arcadia Biosciences Inc Gross Profit Margin for the year ending December 31, 2021 was -28.44%, a -180.59% change year over year.
Arcadia Biosciences Inc Gross Profit Margin for the year ending December 31, 2020 was 35.29%, a 45.25% change year over year.
Arcadia Biosciences Inc Gross Profit Margin for the year ending December 31, 2019 was 24.29%, a -55.71% change year over year.

NASDAQ: RKDA

Arcadia Biosciences Inc

CEO	Ms. Pamela Haley
IPO Date	May 15, 2015
Location	United States
Headquarters	202 Cousteau Place, Davis, CA, United States, 95618
Employees	21
Sector	Consumer Defensive
Industry	Packaged foods

Description

Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. The company was incorporated in 2002 and is headquartered in Dallas, Texas.

Key trends